Despite their promise, mRNA vaccines face several challenges. One major hurdle is the stability of mRNA, which can be easily degraded by enzymes in the body. Researchers are working on nanoparticle delivery systems and other methods to protect mRNA and ensure it reaches its target cells. Additionally, there is the challenge of eliciting a strong and durable immune response without causing excessive inflammation or autoimmunity.
